Bayer and Endeavor Launch Legado 2026: A Capital Opportunity for Entrepreneurs

Alegalis | Bayer, in partnership with Endeavor, launched the third edition of its Legado 2026 program, an initiative aimed at startups that are already operating and generating impact in the fields of health, agriculture, and food security. Unlike many programs that focus on early-stage ideas, this initiative is designed for businesses seeking to scale their operations through strategic support and access to resources.

The program is active in ten Latin American countries, including Guatemala, and selects ten projects to receive specialized mentoring, access to the Legado community, and greater visibility at regional events. In addition, it offers two awards of US$20,000 (more than GTQ150,000), while four of the selected companies will participate in the Impact Minds conference, organized by Latimpacto and scheduled to take place in Brazil in September 2026. Applicants were required to have an operational solution, demonstrate measurable impact in one of the program’s priority areas, and complete the online application form.

In an entrepreneurial ecosystem characterized by intense competition for funding, access to capital remains one of the greatest challenges for growing businesses. Against this backdrop, initiatives promoted by both public and private institutions seek to facilitate access to financial resources that enable promising ventures to expand. The Legado program represents an alternative for Guatemalan startups that are already operating in the market and are looking for support to accelerate their growth.

One of the program’s main differentiators is its focus on companies that already provide solutions with social and environmental impact, a segment that is often underserved by initiatives targeting businesses in their earliest stages. Beyond financial support, the program offers strategic guidance and opportunities to connect with key players across the regional entrepreneurial ecosystem.

From a business perspective, one of the program’s greatest attractions is that the financial awards constitute non-dilutive capital. Unlike investment rounds organized by private equity or venture capital funds, recipients are not required to relinquish equity or assume the obligations typically associated with those transactions. As a result, the awards provide an injection of capital that enables businesses to strengthen their operations without altering their ownership structure or affecting the founders’ control of the company.

From a legal perspective, although the application process is relatively straightforward, participants should nevertheless take certain precautions before entering international competitions of this nature. One of the most significant considerations is intellectual property protection. In sectors such as agriculture and healthcare, startups frequently develop innovative assets whose protection through trademarks, patents, or other intellectual property rights is essential. Accordingly, before publicly disclosing any aspect of their projects, businesses should verify that their intangible assets are adequately protected to avoid jeopardizing their current or future legal protection.